Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Zhengzhong, Han"'
Autor:
Zeqi Zhao, Zhengzhong Han, Yudi Shao, Tingting Tang, Caiji Wang, Bing Xu, Zhenlu Zhao, Xi Shi, Dan Jin, Wei Li
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e40112- (2024)
Chronic otitis media with effusion (COME) is a common cause of hearing loss in children and adults. Laryngopharyngeal reflux (LPR) is often overlooked in the clinical management of COME complicated by LPR. This study aimed to investigate the presence
Externí odkaz:
https://doaj.org/article/822c1a2c8a684a0e9aa9ab67339d384d
Autor:
Yuhan Han, Zhengzhong Han, Xuyang Huang, Shanshan Li, Guoliang Jin, Junfeng Feng, Decheng Wu, Hongmei Liu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract Background Hypothermia is a promising therapy for traumatic brain injury (TBI) in the clinic. However, the neuroprotective outcomes of hypothermia-treated TBI patients in clinical studies are inconsistent due to several severe side effects.
Externí odkaz:
https://doaj.org/article/1730f77c457044a58f3594f4c9fa7d3d
Autor:
Jun Lu, Zongren Zhao, Dong-Mei Wu, Hongmei Liu, Hui Shi, Zhengzhong Han, Yu Rutong, Jun Jia, Haoyue Xu, Shuo Sun
Publikováno v:
International Journal of Nanomedicine. 15:3347-3362
Introduction Temozolomide (TMZ) is the first-line chemotherapeutic option to treat glioma; however, its efficacy and clinical application are limited by its drug resistance properties. Polo-like kinase 1 (PLK1)-targeted therapy causes G2/M arrest and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66955d9b2409ff6ca0bd09d1e33f0f02
https://doi.org/10.2147/ijn.s243878
https://doi.org/10.2147/ijn.s243878
Autor:
Zhengzhong Han, Yuhan Han, Xuyang Huang, Hongwei Ma, Xuefeng Zhang, Jingyuan Song, Jun Dong, Shanshan Li, Rutong Yu, Hongmei Liu
Publikováno v:
Advanced healthcare materials. 11(11)
Survival after severe traumatic brain injury (TBI) depends on minimizing or avoiding secondary insults to the brain. Overproduction of reactive oxygen species (ROS) and Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a37ef4a6c77384929ce5bde8bce90c5c
https://pubmed.ncbi.nlm.nih.gov/35118827
https://pubmed.ncbi.nlm.nih.gov/35118827
Autor:
Yalan Li, Wei Zhuang, Konduru Naveena, Xi Shi, Ting Li, Xuanyi Li, Shiwei Qiu, Yuehua Qiao, Zhengzhong Han, Zeqi Zhao, Hongmei Liu, Guanxiong Lei
Publikováno v:
ACS applied materialsinterfaces. 13(6)
Overproduction of reactive oxygen species (ROS) and inflammation are two key pathogeneses of noise-induced hearing loss (NIHL), which leads to outer hair cell (OHC) damage and hearing loss. In this work, we successfully developed ROS-responsive nanop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ed7d9dbac5aa289a327a476d55c996
https://pubmed.ncbi.nlm.nih.gov/33528239
https://pubmed.ncbi.nlm.nih.gov/33528239
Autor:
Zhengzhong Han, Yuhan Han, Xuyang Huang, Hongwei Ma, Xuefeng Zhang, Jingyuan Song, Jun Dong, Shanshan Li, Rutong Yu, Hongmei Liu
Publikováno v:
Advanced Healthcare Materials. 11:2270056
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::526e09ef2477d96c8d123479f69256ed
https://doi.org/10.1002/adhm.202270056
https://doi.org/10.1002/adhm.202270056
Autor:
Yuhan Han, Yu Rutong, Deyun Zhang, Gang Zhao, Feng Qian, Liu Hongmei, Xuyang Huang, Long Zhang, Zhengzhong Han, Jun Jia, Guoliang Jin, Shanshan Li
Hypothermia is a promising therapy for Traumatic brain injury (TBI) in the clinic. However, the neuroprotective outcomes of hypothermia-treated TBI are not consistent in clinical studies due to several severe side effects. Here, an injectable refrige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba63f5deee0d1eec7cd8cbfd3e7166f7
https://doi.org/10.21203/rs.3.rs-52381/v1
https://doi.org/10.21203/rs.3.rs-52381/v1
Autor:
Hui, Shi, Shuo, Sun, Haoyue, Xu, Zongren, Zhao, Zhengzhong, Han, Jun, Jia, Dongmei, Wu, Jun, Lu, Hongmei, Liu, Rutong, Yu
Publikováno v:
International Journal of Nanomedicine
Introduction Temozolomide (TMZ) is the first-line chemotherapeutic option to treat glioma; however, its efficacy and clinical application are limited by its drug resistance properties. Polo-like kinase 1 (PLK1)-targeted therapy causes G2/M arrest and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec6c6a9b4ad6a5d311108ed64b8c8f2f
https://pubmed.ncbi.nlm.nih.gov/32494134
https://pubmed.ncbi.nlm.nih.gov/32494134
Autor:
Shun Li, Haoyue Xu, Deyun Zhang, Hongmei Liu, Zongren Zhao, Longzhen Zhang, Yuhan Han, Zhengzhong Han, Jun Jia, Yu Rutong
Publikováno v:
Journal of biomedical nanotechnology. 15(9)
Radiotherapy (RT) has become one of the most effective treatments for malignant tumor. Intra-tumoral hypoxia is recognized as a chief reason that induces resistance to radiation. Moreover, the toxicities of RT to normal tissues limits the usage of hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bcfca428bdd91144f11930838345a96
https://pubmed.ncbi.nlm.nih.gov/31387684
https://pubmed.ncbi.nlm.nih.gov/31387684
Autor:
Guoliang Jin, Long Zhang, Deyun Zhang, Hongmei Liu, Zhengzhong Han, Shanshan Li, Feng Qian, Yuhan Han, Gang Zhao, Rutong Yu
Publikováno v:
Biomaterials. 270:120675
Traumatic brain injury (TBI) generates excess reactive oxygen species (ROS), which can exacerbate secondary injury and result in disability and death. Secondary injury cascades can trigger the release of uncontrolled ROS into the surrounding normal b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c615272e87b0cd20e0fd3c04d3a94745
https://doi.org/10.1016/j.biomaterials.2021.120675
https://doi.org/10.1016/j.biomaterials.2021.120675